1. Deep-Learning-Based MRI Microbleeds Detection for Cerebral Small Vessel Disease on Quantitative Susceptibility Mapping.
- Author
-
Xia P, Hui ES, Chua BJ, Huang F, Wang Z, Zhang H, Yu H, Lau KK, Mak HKF, and Cao P
- Subjects
- Humans, Male, Female, Aged, Retrospective Studies, Middle Aged, Algorithms, Brain diagnostic imaging, Sensitivity and Specificity, Image Interpretation, Computer-Assisted methods, Image Processing, Computer-Assisted methods, Cerebral Small Vessel Diseases diagnostic imaging, Deep Learning, Magnetic Resonance Imaging methods, Cerebral Hemorrhage diagnostic imaging
- Abstract
Background: Cerebral microbleeds (CMB) are indicators of severe cerebral small vessel disease (CSVD) that can be identified through hemosiderin-sensitive sequences in MRI. Specifically, quantitative susceptibility mapping (QSM) and deep learning were applied to detect CMBs in MRI., Purpose: To automatically detect CMB on QSM, we proposed a two-stage deep learning pipeline., Study Type: Retrospective., Subjects: A total number of 1843 CMBs from 393 patients (69 ± 12) with cerebral small vessel disease were included in this study. Seventy-eight subjects (70 ± 13) were used as external testing., Field Strength/sequence: 3 T/QSM., Assessment: The proposed pipeline consisted of two stages. In stage I, 2.5D fast radial symmetry transform (FRST) algorithm along with a one-layer convolutional network was used to identify CMB candidate regions in QSM images. In stage II, the V-Net was utilized to reduce false positives. The V-Net was trained using CMB and non CMB labels, which allowed for high-level feature extraction and differentiation between CMBs and CMB mimics like vessels. The location of CMB was assessed according to the microbleeds anatomical rating scale (MARS) system., Statistical Tests: The sensitivity and positive predicative value (PPV) were reported to evaluate the performance of the model. The number of false positive per subject was presented., Results: Our pipeline demonstrated high sensitivities of up to 94.9% at stage I and 93.5% at stage II. The overall sensitivity was 88.9%, and the false positive rate per subject was 2.87. With respect to MARS, sensitivities of above 85% were observed for nine different brain regions., Data Conclusion: We have presented a deep learning pipeline for detecting CMB in the CSVD cohort, along with a semi-automated MARS scoring system using the proposed method. Our results demonstrated the successful application of deep learning for CMB detection on QSM and outperformed previous handcrafted methods., Level of Evidence: 2 TECHNICAL EFFICACY: Stage 2., (© 2023 The Authors. Journal of Magnetic Resonance Imaging published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.)
- Published
- 2024
- Full Text
- View/download PDF